Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Sep 30, 2025 | (FY)Jun 30, 2025 | (Q4)Jun 30, 2025 | (Q3)Mar 31, 2025 | (Q2)Dec 31, 2024 | (Q1)Sep 30, 2024 | (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow (Indirect Method) | ||||||||||
| Cash from operating activities | 265.22%76K | 245.84%5.7M | 73.03%7.15M | -1.44%-913K | 30.74%-489K | 94.75%-46K | -16.97%1.65M | 89.50%4.13M | -14.07%-900K | -167.24%-706K |
| Net profit before non-cash adjustment | 354.95%1.31M | -126.21%-2.56M | -147.06%-2.83M | -59.54%1.24M | -46.95%-457K | -150.54%-515K | 222.23%9.78M | 714.29%6.01M | 1,477.32%3.06M | -105.26%-311K |
| Total adjustment of non-cash items | -1,772.48%-2.04M | 177.25%3.38M | 247.25%5.42M | 50.76%-1.91M | 82.76%-25K | 94.31%-109K | -1,323.16%-4.37M | -73.14%1.56M | -358.41%-3.87M | 97.68%-145K |
| -Depreciation and amortization | ---- | 31.48%271.14K | ---- | ---- | ---- | ---- | -13.23%206.22K | ---- | ---- | ---- |
| -Reversal of impairment losses recognized in profit and loss | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| -Assets reserve and write-off | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| -Disposal profit | -1.83%-390K | 169.00%2.98M | 200.93%4.23M | -374.53%-503K | -5,114.29%-365K | -2,846.15%-383K | -569.46%-4.32M | -455.60%-4.19M | -21.84%-106K | 93.75%-7K |
| -Net exchange gains and losses | ---- | 96.37%-14.18K | ---- | ---- | ---- | ---- | -2,428.56%-390.64K | ---- | ---- | ---- |
| -Pension and employee benefit expenses | ---- | 3.03%92.76K | ---- | ---- | ---- | ---- | -0.57%90.03K | ---- | ---- | ---- |
| -Other non-cash items | -702.55%-1.65M | 21.20%48.39K | -85.69%836.39K | 62.74%-1.4M | 346.38%340K | 114.39%274K | -6.11%39.93K | 11.68%5.84M | -397.09%-3.76M | 97.75%-138K |
| Changes in working capital | 39.10%804K | 229.94%4.89M | 232.58%4.56M | -170.33%-246K | 97.20%-7K | 2,652.38%578K | -167.19%-3.76M | -29.91%-3.44M | 34.53%-91K | -118.01%-250K |
| -Change in receivables | ---- | -1,608.01%-758.36K | ---- | ---- | ---- | ---- | -8,997.80%-44.4K | ---- | ---- | ---- |
| -Change in payables | ---- | 139.87%548.43K | ---- | ---- | ---- | ---- | -182.57%-1.38M | ---- | ---- | ---- |
| -Changes in other current assets | 705.26%805K | 317.74%5.1M | 320.80%5.06M | 93.02%-3K | --177K | -1,562.50%-133K | 23.85%-2.34M | 25.53%-2.29M | ---43K | --0 |
| -Changes in other current liabilities | -100.14%-1K | 139.83%548K | 123.85%264K | -406.25%-243K | 26.40%-184K | 2,351.72%711K | ---1.38M | ---1.11M | 65.47%-48K | -118.01%-250K |
| Dividends paid (cash flow from operating activities) | ||||||||||
| Dividends received (cash flow from operating activities) | ||||||||||
| Interest paid (cash flow from operating activities) | ||||||||||
| Interest received (cash flow from operating activities) | ||||||||||
| Tax refund paid | 85.06%-36K | 83.23%-94.21K | 209.58%308.8K | 78.18%-24K | -100.00%-138K | -138.61%-241K | -77.89%-561.79K | -62.13%-281.79K | -74.60%-110K | -146.43%-69K |
| Other operating cash inflow (outflow) | 0.00%20K | 0 | -1.69%-60K | 0.00%20K | 0.00%20K | 5.26%20K | 0 | 3.28%-59K | -67.21%20K | 200.00%20K |
| Operating cash flow | 122.47%60K | 416.01%5.61M | 95.15%7.4M | 7.37%-917K | 19.60%-607K | 72.16%-267K | -34.92%1.09M | 94.85%3.79M | -25.16%-990K | -175.35%-755K |
| Investing cash flow | ||||||||||
| Net PPE purchase and sale | ---- | --0 | --0 | ---- | ---- | ---- | -280.10%-312.03K | -337,708.89%-304.03K | ---- | ---- |
| Net investment product transactions | 56.58%-508K | 98.39%-634K | 101.80%427K | 56.38%-6.72M | 694.09%6.83M | -208.03%-1.17M | ---39.27M | ---23.78M | -2,586.13%-15.41M | -101.93%-1.15M |
| Dividends received (cash flow from investment activities) | 18.52%32K | 104.67%219K | 187.50%23K | 113.95%184K | -600.00%-15K | 170.00%27K | --107K | --8K | 1.18%86K | -97.06%3K |
| Interest received (cash flow from investment activities) | -16.18%435K | 86.40%2.06K | 44.95%-1.48M | -49.25%442K | -42.83%518K | -42.78%519K | -14.16%1.1K | -112.98%-2.68M | 9.15%871K | 217.89%906K |
| Investing cash flow | 93.43%-41K | 100.66%2.06K | -104.94%-611.94K | 57.85%-6.1M | 3,143.57%7.34M | -131.20%-624K | -284.78%-310.93K | 119.93%12.4M | -1,062.41%-14.47M | -100.40%-241K |
| Financing cash flow | ||||||||||
| Net issuance payments of debt | ---- | -407.98%-30.69K | -307.64%-20.69K | --0 | ---- | ---- | --9.97K | --9.97K | --0 | ---- |
| Cash dividends paid | ---- | ---7.5M | --0 | --0 | ---- | ---- | ---- | ---- | ---- | ---- |
| Interest paid (cash flow from financing activities) | 48.15%-14K | -22.95%-50.45K | -34.05%-13.45K | 20.00%-8K | 81.82%-2K | -170.00%-27K | 6.34%-41.03K | 15.06%-10.03K | 0.00%-10K | 0.00%-11K |
| Financing cash flow | 48.15%-14K | -24,304.12%-7.58M | -52,423.08%-34.14K | 20.00%-8K | -68,190.91%-7.51M | -170.00%-27K | 29.09%-31.07K | 99.45%-65 | 0.00%-10K | 0.00%-11K |
| Net cash flow | ||||||||||
| Beginning cash position | -16.78%45.29M | 32.65%2.81M | -39.38%45.69M | -41.97%52.71M | -41.75%53.5M | -40.08%54.42M | 269.27%2.12M | -16.18%75.37M | 1.81%90.83M | 224.60%91.84M |
| Current changes in cash | 100.54%5K | -365.05%-1.97M | -58.29%6.75M | 54.59%-7.02M | 22.14%-784K | -189.04%-918K | -51.81%744.42K | 126.87%16.19M | -2,302.99%-15.47M | -101.65%-1.01M |
| Effect of exchange rate changes | ---- | 129.99%15.81K | ---- | ---- | ---- | ---- | ---52.72K | ---- | ---- | ---- |
| End cash Position | -15.34%45.29M | -69.65%852.74K | -69.65%852.74K | -39.38%45.69M | -41.97%52.71M | -41.75%53.5M | 32.65%2.81M | 32.65%2.81M | -16.18%75.37M | 1.81%90.83M |
| Free cash flow | 122.47%60K | 719.61%5.61M | 117.75%7.4M | 8.21%-917K | 19.60%-607K | 72.16%-267K | -55.85%683.98K | 74.63%3.4M | -26.30%-999K | -175.35%-755K |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.